Looking for Metacresol Excipient pharmaceutical excipients? Find information on Metacresol Excipient's applications, manufacturers, suppliers, etc. on PharmaCompass.

PharmaCompass

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

FINISHED DOSAGE FORMULATIONS

Upload your portfolio for free, ask us

FDF DOSSIERS SUPPLIERS

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

INSULIN GLARGINE RECOMBINANT

Drug : LANTUS

Dosage Form : INJECTABLE; INJECTION

Application Number : 21081

Country : US

Patented : No

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

INSULIN LISPRO

Drug : ADMELOG SOLOSTAR

Dosage Form : SOLUTION; INTRAVENOUS, SUBCUTANEOUS

Application Number : 209196

Country : US

Patented : No

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

INSULIN LISPRO

Drug : ADMELOG

Dosage Form : SOLUTION; INTRAVENOUS, SUBCUTANEOUS

Application Number : 209196

Country : US

Patented : No

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

INSULIN GLARGINE RECOMBINANT

Drug : LANTUS SOLOSTAR

Dosage Form : INJECTABLE; INJECTION

Application Number : 21081

Country : US

Patented : No

Sanofi Company Banner

05

arrow
Coatings Trends
Not Confirmed
United Kingdom
arrow
Coatings Trends
Not Confirmed

EXENATIDE SYNTHETIC

Drug : BYETTA

Dosage Form : INJECTABLE; SUBCUTANEOUS

Application Number : 21773

Country : US

Patented : No

blank

06

arrow
Coatings Trends
Not Confirmed
United Kingdom
arrow
Coatings Trends
Not Confirmed

PRAMLINTIDE ACETATE

Drug : SYMLIN

Dosage Form : INJECTABLE; SUBCUTANEOUS

Application Number : 21332

Country : US

Patented : No

blank

07

arrow
Coatings Trends
Not Confirmed
U.S.A
arrow
Coatings Trends
Not Confirmed

INSULIN LISPRO RECOMBINANT

Drug : HUMALOG

Dosage Form : INJECTABLE; INJECTION

Application Number : 20563

Country : US

Patented : No

blank

08

arrow
Coatings Trends
Not Confirmed

09

arrow
Coatings Trends
Not Confirmed
U.S.A
arrow
Coatings Trends
Not Confirmed

INSULIN RECOMBINANT HUMAN

Drug : HUMULIN R PEN

Dosage Form : INJECTABLE; INJECTION

Application Number : 18780

Country : US

Patented : No

blank

10

arrow
Coatings Trends
Not Confirmed
U.S.A
arrow
Coatings Trends
Not Confirmed

INSULIN HUMAN

Drug : HUMULIN R

Dosage Form : SOLUTION; SUBCUTANEOUS

Application Number : 18780

Country : US

Patented : No

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EXCIPIENTS BY APPLICATIONS

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty